Drugmakers Agree Zantac Carcinogen Suits Should Go to New Jersey

Sanofi US Services Inc. and other companies that sold branded Zantac products agree with some plaintiffs that suits linking the popular antacids to cancer should proceed in New Jersey.

Plaintiffs in five suits urged the U.S. Judicial Panel on Multidistrict Litigation earlier this month to send the litigation to the U.S. District Court for the District of New Jersey.

The state is home to defendants Sanofi US Services and Sanofi-Aventis U.S. LLC, which are named in many pending suits and manufactured and distributed the drug in the U.S. from about January 2017 until an Oct. 18, 2019, recall, plaintiffs ...